Showing 2,792 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

PrEP policies & guidelines

HIV prevention drugs illustrate just how bad pharmaceutical patents are for our health

Editor's pick
NBC News
3 December 2020
PrEP programmes & uptake

Pre-exposure prophylaxis services in Thailand during COVID-19

Editor's pick
World Health Organization
3 December 2020
Injectable & long-acting PrEP

'A shot can end the stigma': African women pin hopes on anti-HIV jab

Editor's pick
Reuters
3 December 2020
HIV treatment

Top 10 HIV Clinical Developments of 2020

Editor's pick
TheBodyPro
1 December 2020
Vaginal rings & topical PrEP

IPM’s Dapivirine Ring for Women’s HIV Prevention Receives WHO Prequalification

Editor's pick
International Partnership for Microbicides
1 December 2020
PrEP programmes & uptake

Grindr faces fierce backlash after pushing 'misleading' anti-PrEP ads

Editor's pick
Pink News
30 November 2020
Epidemiology & behaviour

1 in 4 new HIV cases at 56 Dean Street in 2020 among people taking break from PrEP

Editor's pick
Attitude
30 November 2020
Condoms & lubricant

How PrEP users decide whether to use condoms

News
30 November 2020
PrEP programmes & uptake

Glasgow outreach service shows the feasibility of PrEP for people who inject drugs

News
24 November 2020
PrEP programmes & uptake

Injectable PrEP tops list as the preferred choice for adolescent girls in Cape Town

Editor's pick
Be In The Know
20 November 2020
Sexually transmitted infections prevention

Almost one in ten HIV PrEP users report buying antibiotics for STI prevention, raising concerns over potential antibiotic resistance

News
20 November 2020
Coronavirus

aidsmapCHAT: series 3, episode 2 Video

November 2020
PrEP programmes & uptake

'Uptake Is Only the First Step' for Effective HIV PrEP Protection

Editor's pick
Medscape (requires free registration)
18 November 2020
Injectable & long-acting PrEP

ViiV Healthcare receives FDA Breakthrough Therapy Designation for investigational, long-acting cabotegravir for HIV prevention

Editor's pick
ViiV press release
17 November 2020
Injectable & long-acting PrEP

Merck Launches Major Trial of Monthly Islatravir PrEP Pill for Women

Editor's pick
POZ
16 November 2020
Injectable & long-acting PrEP

Study of injectable PrEP reports the best efficacy seen yet for any form of PrEP in women

News
13 November 2020
Improving HIV care

For PrEP to Work, Shared Doctor-Patient Decision-Making Is Key

Editor's pick
TheBodyPro
11 November 2020
Injectable & long-acting PrEP

Trial results reveal that long-acting injectable cabotegravir as PrEP is highly effective in preventing HIV acquisition in women

Editor's pick
World Health Organization
10 November 2020
Pharmaceutical industry

GlaxoSmithKline's HIV PrEP challenge looms as ViiV's long-acting drug tops Gilead's Truvada in women

Editor's pick
FiercePharma
10 November 2020
Injectable & long-acting PrEP

HIV prevention injection hailed as a “major breakthrough” for women

Editor's pick
Spotlight
10 November 2020
Injectable & long-acting PrEP

ViiV Healthcare announces investigational injectable cabotegravir is superior to oral standard of care for HIV prevention in women

Editor's pick
ViiV press release
9 November 2020
PrEP programmes & uptake

‘PrEP for Women Too’ Campaign Aims to Bring This Empowering HIV Prevention Tool to More Black and Latinx Women

Editor's pick
TheBodyPro
6 November 2020
Heterosexual men

Eswatini: What do men who have sex with women think about PrEP?

Editor's pick
Avert
4 November 2020
PrEP programmes & uptake

Shared Decision-Making Aids Choice of PrEP

Editor's pick
Medscape (requires free registration)
29 October 2020